Filter by Category:
Jan 03, 2025
CELLINK’s $68M Acquisition of MatTek: A Win for Bioprinting and the VTCRC Community
Feb 14, 2024
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
Feb 01, 2024